content.social-post
97.1% Patient Satisfaction
It's our goal to provide products and services that deliver exceptional results and prioritize your safety¹ and well-being.
content.post-availability.until
Instagram Business
It's our goal to provide products and services that deliver exceptional results and prioritize your safety¹ and well-being. That’s where Motiva® breast implants come in!
🌟 97.1% of patients were satisfied with their results²*
💎 Less than 1% device-related complications¹,³
🌎 Trusted in over 86 countries, worldwide³
Link in bio 🔗 to schedule a consultation today.
#MotivaUSA #BreastImplants #MotivatedByMotiva
1. Establishment Labs® Holdings Corp. Establishment Labs® Notes Presentation of 4-Year Results from Motiva® U.S. IDE Study at The Aesthetic Meeting 2024. https://investors.establishmentlabs.com/press-releases/pressreleasesdetails/2024/Establishment-Labs-Notes-Presentation-of-4-Year-Results-from-Motiva-U.S.-IDEStudy-at-The-Aesthetic-Meeting-2024/default.aspx. Published May 2nd, 2024. Accessed May 28th, 2024.
2. Glicksman C, Wolfe A, McGuire P. The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-Filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: Three-Year Clinical Data. Aesthet Surg J. 2024 Sep 27:sjae134. doi: 10.1093/asj/sjae134. Epub ahead of print. PMID: 39331509.
3. Establishment Labs®, Post-Market Surveillance Preliminary Results Q1 2024. Internal Data on File.
content.post-availability.until
Instagram Business
It's our goal to provide products and services that deliver exceptional results and prioritize your safety¹ and well-being. That’s where Motiva® breast implants come in!
🌟 97.1% of patients were satisfied with their results²*
💎 Less than 1% device-related complications¹,³
🌎 Trusted in over 86 countries, worldwide³
Link in bio 🔗 to schedule a consultation today.
#MotivaUSA #BreastImplants #MotivatedByMotiva
1. Establishment Labs® Holdings Corp. Establishment Labs® Notes Presentation of 4-Year Results from Motiva® U.S. IDE Study at The Aesthetic Meeting 2024. https://investors.establishmentlabs.com/press-releases/pressreleasesdetails/2024/Establishment-Labs-Notes-Presentation-of-4-Year-Results-from-Motiva-U.S.-IDEStudy-at-The-Aesthetic-Meeting-2024/default.aspx. Published May 2nd, 2024. Accessed May 28th, 2024.
2. Glicksman C, Wolfe A, McGuire P. The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-Filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: Three-Year Clinical Data. Aesthet Surg J. 2024 Sep 27:sjae134. doi: 10.1093/asj/sjae134. Epub ahead of print. PMID: 39331509.
3. Establishment Labs®, Post-Market Surveillance Preliminary Results Q1 2024. Internal Data on File.